Author:
Rao Siyuan,Lin Yongpeng,Lin Rui,Liu Jinggong,Wang Hongshen,Hu Weixiong,Chen Bolai,Chen Tianfeng
Abstract
Abstract
Background
As Traditional Chinese Medicine (TCM) drugs, Huangqi and Danshen are always applied in combination for spinal cord injury (SCI) treatment based on the compatibility theory of TCM. Astragalus Polysaccharidesis (APS) and Tanshinone IIA (TSIIA) are the main active ingredients of Huangqi and Danshen, and they both possess neuroprotective effects through antioxidant activities. However, low solubility and poor bioavailability have greatly limited their application. In recent years, selenium nanoparticles (SeNPs) have drawn enormous attention as potential delivery carrier for antioxidant drugs.
Results
In this study, TCM active ingredients-based SeNPs surface decorated with APS and loaded with TSIIA (TSIIA@SeNPs-APS) were successfully synthesized under the guidance of the compatibility theory of TCM. Such design improved the bioavailability of APS and TSIIA with the benefits of high stability, efficient delivery and highly therapeutic efficacy for SCI treatment illustrated by an improvement of the antioxidant protective effects of APS and TSIIA. The in vivo experiments indicated that TSIIA@SeNPs-APS displayed high efficiency of cellular uptake and long retention time in PC12 cells. Furthermore, TSIIA@SeNPs-APS had a satisfactory protective effect against oxidative stress-induced cytotoxicity in PC12 cells by inhibiting excessive reactive oxygen species (ROS) production, so as to alleviate mitochondrial dysfunction to reduce cell apoptosis and S phase cell cycle arrest, and finally promote cell survival. The in vivo experiments indicated that TSIIA@SeNPs-APS can protect spinal cord neurons of SCI rats by enhancing GSH-Px activity and decreasing MDA content, which was possibly via the metabolism of TSIIA@SeNPs-APS to SeCys2 and regulating antioxidant selenoproteins to resist oxidative stress-induced damage.
Conclusions
TSIIA@SeNPs-APS exhibited promising therapeutic effects in the anti-oxidation therapy of SCI, which paved the way for developing the synergistic effect of TCM active ingredients by nanotechnology to improve the efficacy as well as establishing novel treatments for oxidative stress-related diseases associated with Se metabolism and selenoproteins regulation.
Funder
National Natural Science Foundation of China
Natural Science Foundation of Guangdong Province of China
Science and Technology Program of Guangzhou
Special Research for Science and Technology of the Guangdong Provincial Hospital of Chinese Medicine
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,Medicine (miscellaneous),Bioengineering
Reference57 articles.
1. Wang WY, Zhou H, Wang YF, Sang BS, Liu L. Current policies and measures on the development of traditional chinese medicine in china. Pharmacol Res. 2021;163: 105187.
2. Guo N, Chen Y, Yang X, Yan H, Fan B, Quan J, et al. Urinary metabolomic profiling reveals difference between two traditional Chinese medicine subtypes of coronary heart disease. J Chromatogr B Analyt Technol Biomed Life Sci. 2021;1179: 122808.
3. Wang Y, Yang JH, Wan HT, He Y, Xu B, Ai CS, et al. Efficacy of Yangyin Yiqi Huoxue granule () in treatment of ischemic stroke patients with Qi-yin deficiency and blood stasis syndrome: a randomized, double-blind, multicenter, phase-2 clinical trial. Chin J Integr Med. 2021;27(11):811–8.
4. Zheng X, Huang B, Lai Z, Zhu Z, Zeng W, Xuhui LU, et al. Clinical observation of different doses of astragalus compound on patients with spinal cord injury with Qi deficiency and blood stasis. Journal of Wenzhou Medical University. 2017, 47(11): 828-831,835.
5. Liu W, Zhou L, Feng L, Zhang D, Zhang C, Gao Y, et al. BuqiTongluo granule for ischemic stroke, stable angina pectoris, diabetic peripheral neuropathy with Qi deficiency and blood stasis syndrome: rationale and novel basket design. Front Pharmacol. 2021;12: 764669.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献